CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 64 enrolled
Drug / intervention
high resolution MRI (hrMRI)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03292874
NCT03292874N/ACompleted
CompareCT.gov

Evaluation of a Novel High-Resolution Diffusion-Weighted MRI Sequence

Cedars-Sinai Medical Center·interventional·Posted Sep 26, 2017·Updated Apr 3, 2024

In Brief

A clinical study evaluating high resolution MRI (hrMRI) for Prostate Cancer. Completed, enrolled 64 participants across 1 site.

Detailed Summary

This high resolution MRI (hrMRI), along with stand MRI (sMRI) will be obtained at baseline and again in approximately 1 year in patients on prostate cancer active surveillance. Changes in lesion size and ADC values will be assessed on the serial studies. This study evaluates the hypothesis that hrMRI will detect changes that sMRI cannot detect and that these changes will correlate with prostate cancer progression as determined on prostate biopsy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 26, 2017
Enrollment StartSep 13, 2017
Primary CompletionDec 14, 2022
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 8.8 years ago

Interventions

high resolution MRI (hrMRI)other

high resolution MRI (hrMRI) and standard MRI (sMRI) will be obtained at baseline and again in approximately 1 year in patients on prostate cancer active surveillance.